It could act by turning the immunosuppressive “cold tumor” into a “hot tumor” for HCC and provides a potential synergistic anti-tumor effect by combing TACE with anti-PD-(L)1 and molecular targeted therapies [18, 19, 22]. Here, CD274 is linked to neoplasm.